Invasive aspergillosis: A life-threatening complication of short-term steroid treatment

被引:26
作者
Conesa, D
Rello, J
Valles, J
Mariscal, D
Ferreres, JC
机构
[1] HOSP SABADELL,DEPT INTENS CARE,E-08208 BARCELONA,SPAIN
[2] HOSP SABADELL,DEPT INTERNAL MED,BARCELONA,SPAIN
[3] HOSP SABADELL,DEPT MICROBIOL,E-08208 BARCELONA,SPAIN
[4] HOSP SABADELL,DEPT PATHOL,E-08208 BARCELONA,SPAIN
关键词
D O I
10.1177/106002809502901209
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: TO describe a patient with invasive pulmonary aspergillosis related to short-term steroid treatment. CASE SUMMARY: A 78-year-old man with chronic obstructive pulmonary disease (COPD) developed an invasive pulmonary aspergillosis after short-term (less than 1 week) intravenous steroid therapy, The diagnosis was established by recovering Aspergillus fumigatus from a bronchoalveolar lavage and was confirmed by autopsy, with the additional finding of an aspergilloma, DISCUSSION: This case is of interest for 3 reasons: (1) it illustrates that invasive aspergillosis may be followed by a rapidly progressive respiratory failure, even in the absence of a fever; (2) this patient had simultaneously an aspergilloma and an invasive aspergillosis; and (3) it confirms reports indicating that short-term steroid therapy for COPD represents a significant risk factor for opportunistic lung infections, CONCLUSIONS: In patients with COPD who receive even short-term steroid therapy and who have progressive respiratory failure caused by pneumonia, invasive aspergillosis should be suspected early and acted upon accordingly.
引用
收藏
页码:1235 / 1237
页数:3
相关论文
共 9 条
[1]   RAPIDLY PROGRESSIVE RESPIRATORY-FAILURE DUE TO ASPERGILLUS PNEUMONIA - A COMPLICATION OF SHORT-TERM CORTICOSTEROID-THERAPY [J].
CREAN, JM ;
NIEDERMAN, MS ;
FEIN, AM ;
FEINSILVER, SH .
CRITICAL CARE MEDICINE, 1992, 20 (01) :148-150
[2]   SIMULTANEOUS LEGIONELLOSIS AND INVASIVE ASPERGILLOSIS IN AN IMMUNOCOMPETENT PATIENT NEWLY TREATED WITH CORTICOSTEROIDS [J].
JIVA, TM ;
KALLAY, MC ;
MARIN, MG ;
POE, RH .
CHEST, 1993, 104 (06) :1929-1931
[3]  
KARAM GH, 1986, REV INFECT DIS, V8, P357
[4]   CORTICOSTEROID TREATMENT AS A RISK FACTOR FOR INVASIVE ASPERGILLOSIS IN PATIENTS WITH LUNG-DISEASE [J].
PALMER, LB ;
GREENBERG, HE ;
SCHIFF, MJ .
THORAX, 1991, 46 (01) :15-20
[5]   ASPERGILLUS LUNG-DISEASE [J].
PENNINGTON, JE .
MEDICAL CLINICS OF NORTH AMERICA, 1980, 64 (03) :475-490
[6]   INVASIVE PULMONARY ASPERGILLOSIS IN A NON-IMMUNOSUPPRESSED PATIENT - SUCCESSFUL MANAGEMENT WITH SYSTEMIC AMPHOTERICIN AND FLUCYTOSINE AND INHALED AMPHOTERICIN [J].
RODENHUIS, S ;
BEAUMONT, F ;
KAUFFMAN, HF ;
SLUITER, HJ .
THORAX, 1984, 39 (01) :78-79
[7]   NONRESOLVING PNEUMONIA IN STEROID-TREATED PATIENTS WITH OBSTRUCTIVE LUNG-DISEASE [J].
RODRIGUES, J ;
NIEDERMAN, MS ;
FEIN, AM ;
PAI, PB .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (01) :29-34
[8]  
STUCK AE, 1989, REV INFECT DIS, V11, P954
[9]   SERIOUS INFECTIOUS COMPLICATIONS OF CORTICOSTEROID-THERAPY FOR COPD [J].
WIEST, PM ;
FLANIGAN, T ;
SALATA, RA ;
SHLAES, DM ;
KATZMAN, M ;
LEDERMAN, MM .
CHEST, 1989, 95 (06) :1180-1184